NeuScience is a therapeutics company leveraging AI and translational biology to target solid tumor cancers. Our drug discovery platform combines panels of patient-derived tumor cells with machine vision and deep learning to find treatments that target aggressive subpopulations at the single-cell level. We have developed a novel method to learn whole-cell phenotypic biomarkers with detection capabilities far beyond those of gold standard biomarker panels. This precision allows us to probe the true efficacy of highly targeted compounds against the most aggressive subpopulations of cancer cells. Beyond development, our proprietary data encodes transformative insights for clinical trial strategy, hypothesis generation across cancers, and point-of-care treatment.